Literature DB >> 25474126

Standardization of positive controls in diagnostic immunohistochemistry: recommendations from the International Ad Hoc Expert Committee.

Emina E Torlakovic1, Søren Nielsen, Glenn Francis, John Garratt, Blake Gilks, Jeffrey D Goldsmith, Jason L Hornick, Elizabeth Hyjek, Merdol Ibrahim, Keith Miller, Eugen Petcu, Paul E Swanson, Xiaoge Zhou, Clive R Taylor, Mogens Vyberg.   

Abstract

Diagnostic immunohistochemistry (dIHC) has been practiced for several decades, with an ongoing expansion of applications for diagnostic use, and more recently for detection of prognostic and predictive biomarkers. However, standardization of practice has yet to be achieved, despite significant advances in methodology. An Ad Hoc Expert Committee was formed to address the standardization of controls, which is a missing link in demonstrating and assuring standardization of the various components of dIHC. This committee has also developed a concept of immunohistochemistry critical assay performance controls that are intended to facilitate methodology transfer and harmonization in dIHC. Furthermore, the committee has clarified definitions of IHC assay sensitivity and specificity, with special emphasis on how these definitions apply to positive controls. Recommendations for "best laboratory practice" regarding positive controls for dIHC are specified. The first set of immunohistochemistry critical assay performance controls for several frequently used IHC stains or tests is also developed and presented.

Mesh:

Year:  2015        PMID: 25474126     DOI: 10.1097/PAI.0000000000000163

Source DB:  PubMed          Journal:  Appl Immunohistochem Mol Morphol        ISSN: 1533-4058


  19 in total

1.  A Root Cause Analysis Into the High Error Rate in Clinical Immunohistochemistry.

Authors:  Steven A Bogen
Journal:  Appl Immunohistochem Mol Morphol       Date:  2019-02-22

2.  Synthetic Antigen Gels as Practical Controls for Standardized and Quantitative Immunohistochemistry.

Authors:  Kathy J Hötzel; Charles A Havnar; Hai V Ngu; Sandra Rost; Scot D Liu; Linda K Rangell; Franklin V Peale
Journal:  J Histochem Cytochem       Date:  2019-03-18       Impact factor: 2.479

3.  The Importance of Epitope Density in Selecting a Sensitive Positive IHC Control.

Authors:  Kodela Vani; Seshi R Sompuram; Anika K Schaedle; Anuradha Balasubramanian; Monika Pilichowska; Stephen Naber; Jeffrey D Goldsmith; Kueikwun G Chang; Farzad Noubary; Steven A Bogen
Journal:  J Histochem Cytochem       Date:  2017-06-30       Impact factor: 2.479

4.  Levey-Jennings Analysis Uncovers Unsuspected Causes of Immunohistochemistry Stain Variability.

Authors:  Kodela Vani; Seshi R Sompuram; Stephen P Naber; Jeffrey D Goldsmith; Regan Fulton; Steven A Bogen
Journal:  Appl Immunohistochem Mol Morphol       Date:  2016 Nov/Dec

Review 5.  Fit-for-Purpose Immunohistochemical Biomarkers.

Authors:  Emina Emilia Torlakovic
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

6.  Crizotinib inhibition of ROS1-positive tumours in advanced non-small-cell lung cancer: a Canadian perspective.

Authors:  D G Bebb; J Agulnik; R Albadine; S Banerji; G Bigras; C Butts; C Couture; J C Cutz; P Desmeules; D N Ionescu; N B Leighl; B Melosky; W Morzycki; F Rashid-Kolvear; Clin Lab; H S Sekhon; A C Smith; T L Stockley; E Torlakovic; Z Xu; M S Tsao
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

7.  A Novel Technique for the Generation of Multitissue Blocks Using a Carrier.

Authors:  Denise Frosina; Achim A Jungbluth
Journal:  Appl Immunohistochem Mol Morphol       Date:  2016-10

Review 8.  Immunohistochemistry in Investigative and Toxicologic Pathology.

Authors:  Kyathanahalli S Janardhan; Heather Jensen; Natasha P Clayton; Ronald A Herbert
Journal:  Toxicol Pathol       Date:  2018-07-02       Impact factor: 1.902

9.  Boldenone Undecylenate-Mediated Hepatorenal Impairment by Oxidative Damage and Dysregulation of Heat Shock Protein 90 and Androgen Receptors Expressions: Vitamin C Preventive Role.

Authors:  Amany Behairy; Wafaa A M Mohamed; Lamiaa L M Ebraheim; Mohamed Mohamed Soliman; Yasmina M Abd-Elhakim; Nabela I El-Sharkawy; Taghred M Saber; Maha M El Deib
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

Review 10.  Cannabinoid Receptor 1 Inhibition in Chronic Kidney Disease: A New Therapeutic Toolbox.

Authors:  Myriam Dao; Helene François
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-07       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.